Skip to main content
Signal8
Dougan Brady W profile photo

Brady W. Dougan

CIK: 0001878020

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)8 (53.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Humacyte, Inc. logo
HUMA

Humacyte, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 11, 2026
    Award(A)

    Stock Options (right to buy)

    Direct
    0 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 16, 2025
    Award(A)

    Stock Options (right to buy)

    Indirect
    311.1K shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 20, 2025
    Sale(S)
    Indirect
    591.7K shares at avg. $1.58$935K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 19, 2025
    Sale(S)
    Indirect
    1.1M shares at avg. $1.63$1.8M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 18, 2025
    Sale(S)
    Indirect
    549.4K shares at avg. $1.83$1.0M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jun 12, 2025
    Award(A)

    Stock Options (right to buy)

    Direct
    0 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Jan 21, 2025
    Award(A)

    Stock Options (right to buy)

    Indirect
    1.1M shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Dec 19, 2024
    Award(A)

    Stock Options (right to buy)

    Indirect
    525 shares-
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 20, 2024
    Sale(S)
    Indirect
    261.4K shares at avg. $4.40$1.2M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 19, 2024
    Purchase(P)
    Indirect
    1.8K shares at avg. $4.44$8K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 19, 2024
    Sale(S)
    Indirect
    427.5K shares at avg. $4.34$1.9M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Nov 18, 2024
    Sale(S)
    Indirect
    811.2K shares at avg. $4.44$3.6M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Sep 10, 2024
    Sale(S)
    Indirect
    288.7K shares at avg. $5.23$1.5M
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Sep 9, 2024
    Sale(S)
    Indirect
    157.7K shares at avg. $5.42$855K
  • Humacyte, Inc. logo
    HUMA

    Humacyte, Inc.

    Aug 29, 2024
    Purchase(P)
    Indirect
    1.2K shares at avg. $6.54$8K

1-15 of 15

About Dougan Brady W

Dougan Brady W (SEC CIK 0001878020) files insider reports with the SEC as Director of Humacyte, Inc. (HUMA).

Signal8 holds 10 ownership filings by Dougan Brady W, all Form 4s, filed between Sep 3, 2024 and Jun 12, 2026. Those filings report 15 transactions, from Aug 29, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dougan Brady W's filings is in DURHAM, NC.

Recent filings by Dougan Brady W

  • Jun 11, 2026: Grant or award of HUMA derivative securities (Form 4, code A).
  • Nov 16, 2025: Grant or award of HUMA derivative securities (Form 4, code A).
  • Aug 20, 2025: Open-market sale of HUMA shares (Form 4, code S).
  • Aug 19, 2025: Open-market sale of HUMA shares (Form 4, code S).
  • Aug 18, 2025: Open-market sale of HUMA shares (Form 4, code S).

Other insiders filing for Humacyte, Inc. (HUMA)

How to read Form 4 transaction codes